How COVID-19 has affected Biotech's Supply Chain

In today’s global marketplace, antibodies and supporting reagents are sourced from many parts of the globe. For instance, considerable manufacturing and raw material supply for life science reagents originates in Asia. The SARS-CoV-2 pandemic saw a total shutdown of this region, which affected many diverse multibillion-dollar industries.

Going forward, risk mitigation strategies should be developed and deployed to take proactive measures to ensure uninterrupted access to critical supply chain materials. See what our Chief Scientific Officer, Dr. Carl Ascoli and Product Manager, Todd Giardiello have to say: